Efficacy News and Research

RSS
Morphotek announces preliminary data from Phase II trial of farletuzumab

Morphotek announces preliminary data from Phase II trial of farletuzumab

HORIZONS-AMI clinical trial demonstrates efficacy of drug-eluting stent

HORIZONS-AMI clinical trial demonstrates efficacy of drug-eluting stent

Careful follow-up after eradication therapy for peptic ulcer needed

Careful follow-up after eradication therapy for peptic ulcer needed

RXi Pharmaceuticals acquires self-delivering rxRNA technology platform from Advirna

RXi Pharmaceuticals acquires self-delivering rxRNA technology platform from Advirna

NCI awards Altor Bioscience a $3 MM grant to develop its targeted cancer therapeutic ALT-801

NCI awards Altor Bioscience a $3 MM grant to develop its targeted cancer therapeutic ALT-801

US Treasury Department clears YM BioSciences' nimotuzumab clinical program extension

US Treasury Department clears YM BioSciences' nimotuzumab clinical program extension

Phase III PLATO study proves that ticagrelor is more effective than clopidogrel

Phase III PLATO study proves that ticagrelor is more effective than clopidogrel

Non-accredited education programs for people with chronic disabilities

Non-accredited education programs for people with chronic disabilities

The Adiana permanent contraception system supported by UK's NICE

The Adiana permanent contraception system supported by UK's NICE

Phase III clinical trial of investigational HIV vaccine regimen complete

Phase III clinical trial of investigational HIV vaccine regimen complete

NDA submitted to the FDA for new osteoarthritis drug

NDA submitted to the FDA for new osteoarthritis drug

Partial success reported in the Phase 3 trial of HIV/AIDS vaccine

Partial success reported in the Phase 3 trial of HIV/AIDS vaccine

FDA grants priority review for Cephalon's sNDA

FDA grants priority review for Cephalon's sNDA

Experimental HIV vaccine shows promise

Experimental HIV vaccine shows promise

Interim results of a pilot study using BACE cardiac device released

Interim results of a pilot study using BACE cardiac device released

Everolimus-eluting stent efficient in treating native coronary artery lesions

Everolimus-eluting stent efficient in treating native coronary artery lesions

NICE updates its guidance on hysteroscopic sterilization

NICE updates its guidance on hysteroscopic sterilization

Clinical trial comparing Boston Scientific's coronary stent systems

Clinical trial comparing Boston Scientific's coronary stent systems

Octapharma AG submits Biological License Application for its octagam(R) 10% to FDA

Octapharma AG submits Biological License Application for its octagam(R) 10% to FDA

Clinical study results of Novolimus and Myolimum eluting coronary stent systems released

Clinical study results of Novolimus and Myolimum eluting coronary stent systems released

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.